is dedicated to the acceptance, medical treatment, and legal protection of individuals correcting the misalignment of their brains and their anatomical sex, while supporting their transition into society.
TS-Si supports open
and immediate access to
publicly funded research
| Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. |
 |
 |
| Resources - Abstracts | |||||
| TS-Si Research Service | |||||
| Saturday, 13 June 2009 15:16 | |||||
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol. 2004 Jun;24(3):339-42 Authors: Segraves RT, Clayton A, Croft H, Wolf A, Warnock J Premenopausal women meeting operational criteria for idiopathic, acquired, global hypoactive sexual desire disorder were studied in a randomized, double-blind, placebo-controlled, multiple-site escalating dose 112-day trial of bupropion sustained release. Outcome was measured by investigator-rating and self-administered questionnaires. All measures indicated greater sexual responsiveness in women receiving bupropion. The Changes in Sexual Functioning Questionnaire indicated that bupropion had significant effects on increasing measures of sexual arousal, orgasm completion, and sexual satisfaction. PMID: 15118489 [PubMed - indexed for MEDLINE]  The TS-Si Research Service consolidates information on research intiatives and findings relevant to individuals who correct the misalignment of their brains and their anatomical sex. The service tracks key scientific and medical developments at every stage of the process — from early consideration of research opportunities and published findings through practical application in clinical settings. Researchers and students from qualifying institutions regularly receive special emailings from TS-Si that consist of abstracts and other materials that support their interest areas. The TS-Si News Service is a collaborative effort by TS-Si.org editors, contributors, and corresponding institutions. The sources can include the cited individuals and organizations, as well as TS-Si.org staff contributions. Articles and news reports do not necessarily convey official positions of TS-Si, its partners, or affiliates. We welcome your comments. Use the form below to leave a public comment or send private correspondence via the TS-Si Contact Page. We will not divulge any personal details or place you on a mailing list without your permission.Posted: Quote this article on your site To create link towards this article on your website, copy and paste the text below in your page. Preview : 
Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. Saturday, 13 June 2009
Bookmark
Email This
Comments (0)
 Write comment
|
|||||
| Last Updated on Saturday, 13 June 2009 15:16 |
Subscribe to this comment's feed
Show/Hide comments
Show/Hide comment form
The TS-Si News Service
and the TS-Si Research Service
are collaborations of TS-Si officials, staff, contributors, and corresponding institutions. Contents do not necessarily convey official positions of
TS-Si, its partners, or its affiliates. 